Joint ventures are a core part of DaVita's business model, contributing 30% of U.S. dialysis revenue. The company plans to continue forming new JVs, indicating a need for services related to M&A integration, partnership management, and financial consolidation.
Filing excerpt
For the year ended December 31, 2025, revenues from joint ventures in which we have a controlling interest represented approximately 30% of our U.S. dialysis revenues.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kjointVentureGet every 10-K signal for DaVita and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at DaVita this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/dad62ac6-9246-4d8c-8c29-5ab747a157fe returns this record as JSON. POST /v1/companies/enrich returns every signal for davita.com.
{
"signal_id": "dad62ac6-9246-4d8c-8c29-5ab747a157fe",
"signal_type": "sec-10k",
"signal_subtype": "jointVenture",
"detected_at": "2026-02-17T06:37:53.052+00:00",
"company": {
"name": "DaVita",
"domain": "davita.com"
},
"data": {
"detail": "Joint ventures are a core part of DaVita's business model, contributing 30% of U.S. dialysis revenue. The company plans to continue forming new JVs, indicating a need for services related to M&A integration, partnership management, and financial consolidation.",
"metrics": {
"pct": 0.3,
"timeframe": "current_year",
"pct_context": "of U.S. dialysis revenues from joint ventures"
},
"summary": "Joint ventures represent 30% of U.S. dialysis revenue, with plans for continued expansion",
"excerpts": "For the year ended December 31, 2025, revenues from joint ventures in which we have a controlling interest represented approximately 30% of our U.S. dialysis revenues.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/927066/000092706626000012/dva-20251231.htm",
"filing_date": "2026-02-11",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "New entity needs",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/dad62ac6-9246-4d8c-8c29-5ab747a157fe \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"davita.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.